DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs
Srpski
English
Русский
HEART FAILURE THERAPY CHALLENGES IN OBESE PATIENTS
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolic Disorders Zlatibor
Bozkurt B., Aguilar D., Deswal A. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: A scientific statement from the American Heart Association. C
Carbone S., Lavie C.J., Elagizi A., Arena R., Ventura H.O. The impact of obesity in heart failure. Heart Fail Clin. 2020; 16(1): 71–80. doi: 10.1016/j.hfc.2019.08.008
Baena-Díez JM, Byram AO, Grau M, et al. Obesity is an independent risk factor for heart failure: Zona Franca Cohort study. Clin Cardiol. 2010; 33(12): 760–764.
HEART FAILURE THERAPY CHALLENGES IN OBESE PATIENTS
CHARACTERISTICS OF THROMBOPROPHYLAXIS IN ELDERLY PATIENTS BEFORE AND AFTER ORTHOPEDIC HIP AND KNEE SURGER
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolic Disorders, Zlatibor
White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107(1): I4–I8.
Guzon-Illescas O, Perez Fernandez E, Crespí Villarias N, et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019; 14(1): 203. doi:10.1186/s13018-019-1226-6
Bhattacharyya T, Iorio R, Healy WL. Rate of and risk factors for acute inpatient mortality after orthopaedic surgery. J Bone Joint Surg Am. 2002; 84(4): 562–72. doi:10.2106/00004623-200204000-00009
CHARACTERISTICS OF THROMBOPROPHYLAXIS IN ELDERLY PATIENTS BEFORE AND AFTER ORTHOPEDIC HIP AND KNEE SURGER
SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolism Disorders, Zlatibor,
Saeed S, Tadic M, Larsen TH, Grassi G, Mancia G. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021; 39(7): 1282–1292.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418.
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17: 543–58.
SIMILARITIES AND DIFFERENCES OF CARDIOVASCULAR COMPLICATIONS OF COVID-19 INFECTION AND COVID-19 VACCINATION
NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolism Disorders Zlatibor
D Atri, HK Siddiqi, J Lang, V Nauffal, DA Morrow, Bohula EA. COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 202
Terpos I, Ntanasis-Stathopoulos I, Elalamy E, Kastritis TN, Sergentanis M, Politou T, et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020; 95: 834–847. https://doi.org/10.1002/ajh.25829.
Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020; 191: 9–14. https://doi.org/ 10.1016/j
NEW ANTICOAGULANT THERAPY ASPECTS TO THE COVID-19 PATIENTS – FROM PROPHYLAXIS TO COMPLICATIONS TREATMENT THERAPY
Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID–19 infection
English
adjenic74@gmail.comSpecial Hospital for Thyroid Diseases and Metabolism Disorders Zlatibor
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506.
Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020; 192: 152–160.
Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID- 19 pneumonia: a random association? Eur Heart J. 2020; 41( 19):1858.
Pulmonary thromboembolism and pericardial effusion as cardiovascular complications of COVID–19 infection
CONTACT US